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IT is a strange fact that in the voluminous literature on breast cancer the
prognostic value of the size of the tumour is only cursorily dealt with, a fact
mentioned by Geschickter (1945) and underlined by Bloom (1950). The explana-
tion probably is, that the view expressed by Kaae (1948), namely, " It is generally
recognized that the size ofthe tumour is a very important factor in the prognosis,
and that the latter is much more favourable for the small tumours than for the
large," seems so generally sound, even self evident, that the problem has not
been considered worthy of a closer study.
If we examine the pertinent literature, we find, however, that the findings
are not unequivocal.
Dahl Iversen (1930) states that breast cancers up to the size of plums are
without recurrences after 3 years' observation in 83 per cent ofthe cases, whereas
tumours larger, up to the size of a hen's egg, show only 13 per cent freedom from
recurrences after 3 years. Eggers, de Cholnoky and Jessup (1941) report upon a
5-year survival of 73 per cent, if the mass is 2 cm. or less, and only 24 per cent
ifthe mass has reached a size of 3 to 6 cm. Haagensen and Stout (1943) found a
5-year clinical cure of 62*2 per cent if the tumour was under 3 cm. and only
19-8 per cent if the tumour had reached 6 cm. or more. They conclude that
" The data indicate, as might be expected, that the prognosis becomes worse
as the size ofthe tumour increases ".
Bloom (1950) found 5-year survivals in the following percentages: tumour
less than 1 inch 59 per cent, 1 to 2 inches 45 per cent, and more than 2 inches
32 per cent, and he finds after grading of the tumours that: " Of the tumours
with a diameter of 1 inch or less, 37 per cent are classified as Grade I and 23 per
cent as Grade III. On the other hand, in the case of growths of more than
2inches diameter only 8per cent belongto GradeI whilst 54percent are Grade III.
When the diameter lies between 1 and 2 inches the incidence of these tumours
is practically the same ", and he concludes that: " Whether the tumours are small
or large, the outlook is uniformly good in theformer (Grade I) and bad in the latter
group (Grade III). On the other hand, an intermediate result is obtained for
the intermediate cases (Grade II), the survival rate being practically halved in
the presence of the larger neoplasms. In other words, the metastasizing power
for Grade I and also Grade III cancers is independent of size. For growths
classified as Grade II this power bears a direct relationship to the diameter, the
larger the tumour the greater the likelihood of spread having taken place ". Most
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the time factors are so long or so short that their significance is obscured under
the usual clinical conditions.
When Kunath (1940) says: "Size and ma88.-An analysis of this point
failed to reveal that a larger tumour carries any more serious a prognosis than
does a small one ", and Hoopes and McGraw (1942) likewise conclude: " No
correlation was found between the post-operative duration of life and the size
of the tumour removed ", these findings are not necessarily in contradiction to
the opposite conclusions, mentioned above. The explanation may be a different
composition ofthe groups oftumours, as regard number ofrepresentatives ofthe
different grades ofmalignancy. Again we have to guard ourselves in transferring
conclusions from groups to individual cases.
Considering the importance of assessing the significance of a minimum size
of tumour for the prognosis of breast cancer, we have examined breast cancer
material consisting of a total of 974 cases. We planned to examine the ultimate
development of breast cancers as small as practically diagnosable. In order to
decide the upper limit of the size to include, theoretical and practical considera-
tions have been taken into account. Firstly, we considered the smallest lump,
distinguishable as a definite tumour. That size evidently depends upon the site
and upon the amount of adipose tissue. A tumour near the surface and in a
shrunken atrophic breast will be more easily discovered than one deeply situated
in a full and developed breast. It seems that tumours smaller than those the size
of a pea cannot reasonably be distinguished from the many irregular nodosities
in a cimacteric, or pre-cimacteric breast, and in most cases it is difficult to feel
a lump smaller than a small hazel nut. Secondly, we wanted to examine tumours
of a size so small that the number of cases would represent a very small fraction
of the total, whereby we would obtain a statistical claim to a designation " a
very small breast tumour ". The size of our tumours is not given in centimetres,
or millimetres. The tumours are usually characterized by some object for com-
parison, usually: pea, bean, nut kernel, hazel nut, date-stone, date, wall nut,
plum, etc. A tumour the size of a hazel nut will usually measure some 10 to 12
by 15 to 17 mm. One has to have in mind the small size of a Norwegian hazel
nut to appreciate the size.
When we examined our total material we found that only 56 tumours out of
974, i.e., 5-7 per cent. had the size of a hazel nut, or were smaller, and only 10
tumours (1 per cent) were recorded as large as a pea, or a bean. This indicates
that we have found a suitable standard, covering our demand for a diagnosis
of a breast tumour as small as practically diagnosable. Ifsmaller nodules should
be removed for diagnostic or prophylactic purposes, the number of amazons
would reach such proportions that a general reaction from the population would
be the result.
Our conclusion is further substantiated by the previous papers dealing with
this problem. Table I shows the standards and the relative occurrence of the
smallest groups recorded:
TABLE I.-The Maximum Size of the Breawt Tumoura and the Relative
Occurrence of the Size Mentioned.
cm.
Eggers, Cholnoky and Jessup (1941) . 1 . 6 per cent of all.
2 . 15
Bloom (1950) . . . 2-5 (1 in.) 50 ,.,
Haagensen and Stout (1943) . . 3 . 15
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The present material consists ofbreasts andlymphnodes received for diagnosis
from city and county hospitals, as well as from private surgeons, during the years
1933 to 1942. It is representative, and comparable to any other large, average
similar material in Scandinavia. It should comprise cases with at least 75 per
cent operability and include a fair number of " early " cases, as the population
is rather cancer conscious, being under a constant barrage of cancer propaganda
with promises of great hopes of cure if presenting themselves for treatment at an
early stage. The fate of the patients has been followed for from 10 to 20 years.
The material was examined during the later half of 1952.
The clinical information is not always precise, or detailed, as some ofthe case
histories are very short. Nor is the pathological material always complete, as
some ofthe surgeons do not submit adipose tissue from the axilla if no suspicious
glands are found. In other cases a selection ofglands only are sent to the labora-
tory, and finally, some of our paraffin blocks were destroyed during the war,
with the result that for some cases a few slides only could be examined. This
means that all the positive findings are minimum recordings.
The clinical follow-up has been complete, all patients having been accounted
for. Reliable death certificates have been received for all the dead, and the
patients alive have been personally examined by one of us, or by competent
doctors as regards the patients living in remote parts of the country.
As only the patients with a definite statement as to the size ofthe tumour have
been included, the size is known in all cases. The designations have been:
slightly larger than a hazel nut, 10 cases; plum stone, 1 case; half a wall nut,
1 case; hazel nut, 22 cases; nut kemel, 11 cases; pea nut, 1 case; pea, or bean,
10 cases.
Grade ofmalignancy ofthe primary tumour, 11 cases were recorded as Grade I,
28 cases as Grade II, and 17 cases as Grade III.
Axillary lymph nodes were submitted for examination in 31 cases, lymph
nodes not examined in 25 cases.
Treatment varied. In 7 cases a local operation only, and in 7 cases radical
operation was performed. In all the other cases the operation was combined
with radiological treatment, before, or after the operation, or both. In some
cases X-rays were used, in other cases tele-radium. As information is sparse,
details are omitted. No conclusions willbe drawn as to themethods oftreatment,
other than to state that the patients have received the varied treatment offered
the average breast cancer patient in Norway.
The duration of symptoms, that is, the interval between the first recorded
symptom until treatment was commenced, was recorded in 41 cases.
Theperiodofsurvivalhas been calculated from the commencement oftreatment
up to the death ofthe patient, or the day of clinical examination during 1952.
RESULTS.
In Table II is recorded the findings as regards the question of symptom-free
survival for the 5 years' and the 10 years' observation.
TABLE II.-Total Number (56 Cases); Alive, Symptom-free.
After 5 years . 37 . 66 per cent
After 10 years 36 . 64 ,,
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In this table all dead during the period are without reservation, counted as
dead from breast cancer. No 2 died 14 days after operation, when leaving the
hospital. No. 43 died a sudden death 6 months after operation, and No. 8 died
from broncho-pneumonia one year and a half after operation, symptom-free.
All the others succumbed to their tumours.
This 5-year oure rate corresponds very closely to the rate quoted by Engelstad
(1948) for his group of 768 cases, regarded as Stage I and Stage II cases. This
indicates that our " small " breast cancers do not present a particularly favourable
clinical picture.
In one aspect our Table II shows a remarkable deviation from the usual,
namely, the small difference between the 5-year and the 10-year figures, only
1 out of 37 patients dying in the second 5-year interval.
As stated, the whole group of 56 patients has been followed for 10 years.
A smaller group has, however, been followed for a longer period, and in Table III
some of the results are summarized. The 11 years' observation group ends by
the material of the 1941 group, the 12 years' observation material ends by the
1940 group and so on. As therefore the material is not identical in all groups,
it is evident that the results may present features which may look inconsistent at
thefirst impression. Thefindings forthe 11th to 14th years are given in Table III.
TABLE III.-Alive, Symptom-free.
After 11 years . 31 oust of 48 . 65 per cent . (No. 27 died symptom-free.
No. 28 and 29 with meta-
stases, dying next year.)
12 ,, . 24 ,, 40 . 60 ,, . (No. 10 died symptom-free.
No. 30 with metastases,
dying next year.)
,, 13 ,, . 15 ,, 35 . 43 ,, . (No. 31 died symptom-free.
No. 20, 24, 32 with meta-
stases, dying next year.)
,, 14 ,, . S ,, 17 . 47 ,
Table III shows the very important fact that a considerablenumber ofpatients
arrive at the 10 years' limit in apparently good condition, but that nevertheless
they are bearers of silent metastases, which eventually terminate their lives.
As 17 patients only, out of the total of 56, have been followed for as long as
14 years, a number of fatal metastases are probably due among the remaining,
and we may conclude that more than halfofall the patients presenting themselves
with a tumour, the size of a small hazel nut, or smaller, are potential victims of
EXPLANATION OF PLATE.
FIG. 1.-G. N-, 61 years old. J. No. 280/38. Carcinoma Grade I. Size: hazel nut.
Symptoms two weeks. Radical operation. Post-operative radium treatment. 14 years'
observation. Symptom-free. x 135.
FIG. 2.-W-, 48 years old. J. No. 2507/40. Carcinoma Grade I. Size: hazel nut. " Brief"
case history. Radical operation. Post-operative X-rays. Symptom-free, 12 years'
observation. x 135.
FIG. 3.-M. E-, 55 years old. J. No. 1721/40. Carcinoma Grade I. Size: bean. Unknown
duration of symptoms. Radical operation. Post-operative X-rays. Symptom free, 12
years' observation. x 135.
FIG. 4.-L. S-, 60 years old. J. No. 554/40. Carcinoma Grade III. Size: hazel nut.
Symptoms a few days. Radical operation. Three lymph nodes and perinodular adipose
tissue infiltrated by tumour cells. The picture is from one of the lymph nodes. Post-
operative X-rays. Symptom-free, 121 years' observation. x 155.
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their cancer, when given the average treatment in use in Norway. Even if we
select the very smallest tumours present in our series, those the size of a pea
or a bean, out ofa total of 10, we find only 5 patients alive after 10 years, or more,
and 4 patients dead from metastases.
In the present series the combined surgical and radiological treatment seems,
in a number of cases, to have effected a considerable delay in a finally fatal
outcome. This delay is of very great value from a therapeutic standpoint, even
if the treatment fails to effect a complete cure.
The prolonged observation also helps to assess more accurately the real stage
ofthetumours. Stagingactuallyis anambiguous process. Thesimplestandleast
reliable staging is the immediate clinical, unreliable to a degree to make it practi-
cally useless. The anatomical staging is somewhat more precise, and, in lack
of anything better, the accepted basis for grouping of tumours for comparison of
therapeutic results. We have, however, to bear in mind that the value even of
this grouping is rather limited. Negative findings of tumour cells in lymph
nodes removed may be the result of the pathologist not finding the cells in spite
of their presence. Or, tumour cells may by-pass the usual lymphatic filters in
the axillary glands and proceed directly to the supraclavicular or the intrathoracic
nodes, or the tumour cells may spread via the blood stream. The discrepancy
between the number of tumours anatomically staged as Stage I and the number
of cures effected after a proper local operation shows the degree of failure in the
process of staging. The average failure is generally at least 20 per cent. The
final and most accurate staging is aretrospective process, taking into consideration
the outcome of the cancerous growth. A number of patients staged as Stage I
eventually through the clinical development are shown to be in Stage II, or
further. On the other hand, if radiological treatment has been added to the
surgical, even the delayed retrospective clinical staging may be incomplete,
because a tumour, anatomically staged as Stage I and actually being in Stage II,
may be cured by radiological treatment and thereby escape its proper staging.
In spite of the incomplete clinical and pathological information, it will be of
some interest to examine the state of affairs, as regards stages recorded in this
material. The data available are shown in Table IV.
TABLE IV.-Stages: Status by the end of 1952.
Alive, symptom-free. Dead, and patients
Minimum 10 years. living with
metastases.
Lymph nodes negative . 13 . 7
One lymph node invaded 3 5 1 6 Several lymph nodes invaded 2 5
State oflymph nodes unknown 9 . 16*
Total . . . 27 . 29
* No. 10, 27, 31 died symptom-free after more than 10 years' observation.
The large number of fatal outcomes with negative findings of tumour cells in
the axillary lymph nodes confirm our assumption that our figures represent
minimum findings. The considerable number ofpatients alive and symptom-free
in spite ofpositive findings oftumour cells in the lymphnodes, actually 5 patients,
further confirm our statement as to a considerable effect of the treatment, but
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also underlines the great number of patients already in Stage II (or further) at
the moment ofpresenting a very small breast cancer.
Ifwe add these 5 patients with microscopical lymph-node metastases, but still
symptom-free, to the group ofthe dead and those living with metastases, we find
that two-thirds ofall our patients with small tumours were in Stage II (or further)
when the operation was performed.
The value of Bloom's (1950) grading and analysis of his material made it
natural to try his principles on our material. We deliberately use the word
principles, because any grading is arbitrary, and the designation in each case is
the result of a subjective estimate of a series of characteristics, which themselves
are unprecise. With this reservation, which possibly will be further substantiated
by our findings, we present our material in Table V.
TABLE V.-Grad8es: Status of our Material by the end of 1952.
Alive, symptom-free. Dead, or patient living
Minimum 10 years. with metastases
(known).
GradeI . . . 11 . 0
pIII 7}15 0 }30
Total . . . 26 . 30
* No. 10, 27, 31 died symptom free after more than 10 years' observation.
This survey confirms theimportance ofrecognizing and consideringtheGrade I
cases when statistics are prepared of breast cancer materials. All our Grade I
patients, a total of 11, and 20 per cent ofthe whole group, are alive, one of them
having presented tumour cells in an axillary lymph node. It may be pertinent
to note that all these tumours designated as Grade I are histologically definite
carcinomas, not merely cases of " atypical proliferation ", "carcinoma in situ ",
or similar conditions (Fig. 1, 2, 3). On the other hand, however, we have not
succeeded in registering clinical evidence of an increasing malignancy with the
passing from Grade II to Grade III. The explanation may be that the number
of cases is too small, that the treatment given may have influenced the final
result because a number of very malignant tumours are comparatively radio-
sensitive, or it may be caused by our incompetency. We reproduce the histo-
logical picture of one of our most malignant tumours (Case No. 36), recorded as
Grade III and with 3 lymph nodes invaded. The patient is still alive and feeling
well nearly 13 years after the diagnosis was made (Fig. 4). She had radical
mastectomy, and afterwards was given a series of X-ray treatments at one of
our county hospitals (Telemark Fylkessykehus). This case, as well as some
others, show that in individual cases all hope shall not be given up, even if the
situation looks very dark.
Ifwe return to our Grade I cases, we find that these tumours represent a little
more than 40 per cent ofall the patients alive and symptom-free. Ifwe therefore
deduct these tumours from the material assembled in Tables II and III we find
a considerably less favourable result, as shown in Table VI.
Table VI shows that ifwe exclude the Grade I tumours, which actually have
a very low malignancy, approximately two-thirds of the patients in our series
have died or will die from their breast cancers.
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TABLE VI.-Alive and Symptom-free. All Cases, less Grade 1.
Years. Per cent.
5 . 26 outof 45 . 58
10 . 25 ,, 45 . 56
11 . 20 ,, 37 . 54
12 . 14 ,, 30 . 47
13 . 8 ,, 28 . 29
14 5 ,, 14 . 36
In Table VII are collected the data as regards duration of symptoms and
prognosis.
TABLE VII.-Duration ofSymptoms and Prognosis.
4 weeks. 2-3 months. 4-6 months. 7-12 months. More than 1 year.
Alive, symptom-free 10 (4) * 4 * 2 (2) . 1 * 5 (3)
Dead, or alive with
metastases . 6 . 3 . 2 . 6 . 2
This table does not include all cases, but only those where the duration of
symptoms before treatment is known. Grade I cases in brackets.
At a first sight there seem to be two comparatively favourable periods:
a relatively good prognosis for the patients with a very short (4 weeks) and for
those with a very long (more than a year) history of symptoms. The medium
long histories, from a few months up to a year, show an increasingly gloomy
picture.
If we again deduct the Grade I cases we conserve the pattem, and still find
indications of a benefit for very quick reaction with immediate treatment after
diagnosis, and with a still more pronounced bad prognosis in cases with delays
from a few months up to a year. For the very long histories (more than a year)
the comparatively better prognosis is preserved, and may partly be accounted
for by a default in the process of grading, partly by combination of high malig-
nancy and high grade radiosensitivity in certain cases, and partly by inclusion
of tumours with a more moderate malignancy (Grade II). Besides, a perfect
correspondence between morphological grading and biological development is
evidently not obtainable. Too many unknown factors are involved here. To
elucidate this question a larger material is necessary.
SUMMARY AND CONCLUSIONS.
The present study of the fate of patients presenting mammary carcinomas
the size ofa hazel nut, or smaller, shows that onehalfofthe group have eventually
succumbed to their tumour. If we deduct the Grade I tumours, one-third only
of the patients survives. At the commencement of treatment two-thirds ofthe
patients are in Stage II, or further.
The combined surgical and radiological treatment seems to have effected a
considerable delay in the progress of the cancerous growth, and in some cases
to have resulted in a complete cure, even when axillary metastases were present.
The delayed development of the tumours is manifested by an insignificant dif-
ference in the 5 years (66 per cent) and the 10 years (64 per cent) figures' for
" alive symptom-free " and by the ocourrence of a significant number of meta-
stases after the tenth year of observation after treatment.
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Conclu8ion.-The small malignant mammary tumours give, as a group, not
decidedly, or appreciably, more favourable prognosis than an average group of
breast cancers belonging to the ordinary average group of Stage I and Stage II
cases undergoing the same type oftreatment.
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